Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complications of smallpox vaccination, 1968.

× No keyword cloud information.

99 in total

1. Evaluation of therapeutic interventions for vaccinia virus keratitis.

Authors: Sharon Altmann; Curtis R Brandt; Christopher J Murphy; Ravi Patnaikuni; Teresa Takla; Megan Toomey; Brittany Nesbit; Kimberly McIntyre; Jill Covert; Richard Dubielzig; Gary Leatherberry; Elizabeth Adkins; Shantha Kodihalli
Journal: J Infect Dis Date: 2011-01-28 Impact factor: 5.226

2. Bioterrorism and compulsory vaccination.

Authors: Tom Jefferson
Journal: BMJ Date: 2004-09-04

Review 3. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors: L Cárdenas; J D Clements
Journal: Clin Microbiol Rev Date: 1992-07 Impact factor: 26.132

4. Smallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.

Authors: Rafal J Zielinski; Jeremy V Smedley; Pin-Yu Perera; Peter M Silvera; Thomas A Waldmann; Jacek Capala; Liyanage P Perera
Journal: Vaccine Date: 2010-08-20 Impact factor: 3.641

Review 5. Clinical development of Ebola vaccines.

Authors: Saranya Sridhar
Journal: Ther Adv Vaccines Date: 2015-09

6. Susceptibility to vaccinia virus infection and spread in mice is determined by age at infection, allergen sensitization and mast cell status.

Authors: Joanne Domenico; Joseph J Lucas; Mayumi Fujita; Erwin W Gelfand
Journal: Int Arch Allergy Immunol Date: 2012-01-26 Impact factor: 2.749

7. Comparison of smallpox outbreak control strategies using a spatial metapopulation model.

Authors: I M Hall; J R Egan; I Barrass; R Gani; S Leach
Journal: Epidemiol Infect Date: 2007-01-12 Impact factor: 2.451

Review 8. Initiation of primary anti-vaccinia virus immunity in vivo.

Authors: Matthew A Fischer; Christopher C Norbury
Journal: Immunol Res Date: 2007 Impact factor: 2.829

9. Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Authors: Richard N Greenberg; Edgar Turner Overton; David W Haas; Ian Frank; Mitchell Goldman; Alfred von Krempelhuber; Garth Virgin; Nicole Bädeker; Jens Vollmar; Paul Chaplin
Journal: J Infect Dis Date: 2012-12-07 Impact factor: 5.226

Review 10. Vaccinia virus: a suitable vehicle for recombinant vaccines?

Authors: C Kaplan
Journal: Arch Virol Date: 1989 Impact factor: 2.574